Adherence to Antipsychotic Drug Measured by an Arabic Version of Morisky Scale

References

• Al-Jaddou, H., & Malkawi, A. (1997). Prevalence, recognition and management of mental disorders in primary health care in Northern Jordan. Acta Psychiatrica Scandinavica, 96(1), 31–35.
   PubMed Web of Science ®Google Scholar
• Almond, S., Knapp, M., Francois, C., Toumi, M., & Brugha, T. (2004). Relapse in schizophrenia: Costs, clinical outcomes and quality of life. The British Journal of Psychiatry, 184(4), 346–351.
   PubMed Web of Science ®Google Scholar
• Al-Qazaz, H. K., Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice, 90(2), 216–221.
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X., & Conley, R. R. (2010). The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry, 10(1), 2.
   PubMed Web of Science ®Google Scholar
• Aşılar, R. H., Gözüm, S., & Çapık, C. (2014). Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg, 14, 692–700.
   PubMedGoogle Scholar
• Australian Medicine Handbook. (2015). Australian Medicines Handbook. Adelaide, Australia: Australian Medicines Handbook Pty Ltd.
   Google Scholar
• Barkhof, E., Meijer, C. J., de Sonneville, L. M., Linszen, D. H., & de Haan, L. (2012). Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–a review of the past decade. European Psychiatry, 27(1), 9–18.
   PubMed Web of Science ®Google Scholar
• Bates, J., Whitehead, R., Bolge, S., & Kim, E. (2010). Correlates of medication adherence among patients with bipolar disorder: Results of the bipolar evaluation of satisfaction and tolerability (BEST) study: A nationwide cross-sectional survey. Primary Care Companion to the Journal of Clinical Psychiatry, 12(5),333–338.
   Google Scholar
• Bhugra, D. (2005). The global prevalence of schizophrenia. PLoS Med, 2(5), e151.
   PubMed Web of Science ®Google Scholar
• Bland, J., & Altman, D. (1996). Measurement error. British Medical Journal, 313(7059), 744.
   PubMed Web of Science ®Google Scholar
• Bloom, D. E., Cafiero, E., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L. R., Fathima, S.…, & O'Farrell, D. (2012). The global economic burden of noncommunicable diseases (No. 8712). Program on the Global Demography of Aging. Geneva: World Economic Forum.
   Google Scholar
• Bogart, K., Sook Kuan, W., Lewis, C., Akenzua, A., Hayes, D., Prountzos, A…., Kravariti, E. (2014). Mobile phone text message reminders of antipsychotic medication: is it time and who should receive them? A cross-sectional trust-wide survey of psychiatric inpatients. [Article]. BMC Psychiatry, 14(1), 1–17. doi:10.1186/1471-244x-14-15
   Web of Science ®Google Scholar
• Brislin, R. W. (1970). Back-Translation for cross-cultural research. Journal of Cross-cultural Psychology, 1, 185–216.
   Web of Science ®Google Scholar
• Brislin, R. W. (1986). Translation and content analysis of oral and written materials. in Handbook of cross-cultural psychology: Methodology, H. C. Trialdis & J. W. Berry (eds.). Boston, MA: Allyn and Bacon.
   Google Scholar
• Brislin, R. W., Lonner, W. J., & Throndike, R. M. (1973). Cross-Cultural Research Methods. New York, NY: Wiley.
   Google Scholar
• Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russell, C. L. (2009). Interventions to improve medication adherence among older adults: Meta-analysis of adherence outcomes among randomized controlled trials. The Gerontologist, 49(4), 447–462.
   PubMed Web of Science ®Google Scholar
• Eiring, Ø., Landmark, B. F., Aas, E., Salkeld, G., Nylenna, M., & Nytrøen, K. (2015). What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders. British Medical Journal Open, 5(4), e007848. doi:10.1136/bmjopen-2015-007848
   Web of Science ®Google Scholar
• Eticha, T., Teklu, A., Ali, D., Solomon, G., & Alemayehu, A. (2015). Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. [Article]. PLoS ONE, 10(3), 1–11. doi:10.1371/journal.pone.0120560
   Web of Science ®Google Scholar
• Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23(4), 637–651. doi:10.1093/schbul/23.4.637
   PubMed Web of Science ®Google Scholar
• Gbiri, C., Badru, F., Ladapo, H., & Gbiri, A. (2011). Socio-economic correlates of relapsed patients admitted in a Nigerian mental health institution. International Journal of Psychiatry in Clincal Practice, 15(1), 19–26.
   PubMed Web of Science ®Google Scholar
• George, D., & Mallery, P. (2003). SPSS for Windows step by step: A simple guide and reference. 11.0 update (4th ed.). Boston, MA: Allyn & Bacon.
   Google Scholar
• Gray, R., Leese, M., Bindman, J., Becker, T., Burti, L., David, A…., Tansella, M. (2006). Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. The British Journal of Psychiatry, 189(6), 508–514. doi:10.1192/bjp.bp.105.019489
   PubMed Web of Science ®Google Scholar
• Guszkowska, M. (2003). Effects of exercise on anxiety, depression and mood. Psychiatria Polska, 38(4), 611–620.
   Google Scholar
• Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: Challenges and management strategies. Patient Related Outcome Measures, 5, 43–62 .
   PubMedGoogle Scholar
• Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database Systematic Review, 2(2).
   PubMed Web of Science ®Google Scholar
• Hegedüs, A., & Kozel, B. (2014). Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review. International Journal of Mental Health Nursing, 23(6), 490–497. doi:10.1111/inm.12089
   PubMed Web of Science ®Google Scholar
• Howe, C. J., Jawad, A. F., Tuttle, A. K., Moser, J. T., Preis, C., Buzby, M., & Murphy, K. M. (2005). Education and telephone case management for children with type 1 diabetes: A randomized controlled trial. Journal of Pediatric Nursing, 20(2), 83–95.
   PubMedGoogle Scholar
• Hudson, T. J., Owen, R. R., Thrush, C. R., Han, X., Pyne, J. M., Thapa, P., & Sullivan, G. (2004). A pilot study of barriers to medication adherence in schizophrenia. The Journal of Clinical Psychiatry, 65(2), 1,478–216.
   Google Scholar
• International Data Base. (2004). Incidence (annual) of Mental illness. US Census Bureau USA.
   Google Scholar
• Julius, R. J., Novitsky, M. A. J., & Dubin, W. R. (2009). Medication Adherence: A Review of the Literature and Implications for Clinical Practice. Journal of Psychiatric Practice, 15(1), 34–44 doi:10.1097/1001.pra.0000344917.0000343780.0000344977.
   PubMed Web of Science ®Google Scholar
• Kane, J. M., Kishimoto, T., & Correll, C. U. (2013). Non-adherence to medication in patients with psychotic disorders: Epidemiology, contributing factors and management strategies. World Psychiatry, 12(3), 216–226. doi:10.1002/wps.20060
   PubMed Web of Science ®Google Scholar
• Klingberg, S., Schneider, S., Wittorf, A., Buchkremer, G., & Wiedemann, G. (2008). Collaboration in outpatient antipsychotic drug treatment: Analysis of potentially influencing factors. Psychiatry Research, 161(2), 225–234.
   PubMed Web of Science ®Google Scholar
• Knapp, M., King, D., Pugner, K., & Lapuerta, P. (2004). Non-adherence to antipsychotic medication regimens: Associations with resource use and costs. The British Journal of Psychiatry, 184(6), 509–516.
   PubMed Web of Science ®Google Scholar
• Kripalani, S., Yao, X., & Haynes, R. B. (2007). Interventions to enhance medication adherence in chronic medical conditions: A systematic review. Archives of Internal Medicine, 167(6), 540–549.
   PubMedGoogle Scholar
• Lacro, J., Dunn, L., Dolder, C. R., Leckband, S., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literture. The Journal of Clinical Psychiatry, 63(10), 892–909.
   PubMed Web of Science ®Google Scholar
• Leucht, S., & Heres, S. (2006). Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Journal of Clinical Psychiatry, S5(67), 3–8.
   Google Scholar
• Magura, S., Rosenblum, A., & Fong, C. (2012). Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. The Open Addiction Journal, 4, 58–64. doi:10.2174/1874941001104010058.
   Google Scholar
• Morisky, D., Ang, A., Krousel-Wood, M., & Ward, H. (2008). Predictive validity of a medication adherence measure for hypertension control. Journal of Clinical Hypertension, 10(5), 348–354.
   PubMed Web of Science ®Google Scholar
• Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
   PubMed Web of Science ®Google Scholar
• The National Mental Health Team. (2010). National Report on Mental Health System and Services in Jordan. Amman The Higher Council for Science and Technology. Amman.
   Google Scholar
• Peterson, A. M., Takiya, L., & Finley, R. (2003). Meta-analysis of trials of interventions to improve medication adherence. American Journal of Health-System Pharmacy, 60(7), 657–665.
   PubMed Web of Science ®Google Scholar
• Robinson, D. G., Woerner, M. G., Alvir, J. M. J., Bilder, R. M., Hinrichsen, G. A., & Lieberman, J. A. (2002). Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research, 57(2), 209–219.
   PubMed Web of Science ®Google Scholar
• Sakthong, P., Chabunthom, R., & Charoenvisuthiwongs, R. (2009). Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Annals of Pharmacotherapy, 43(5), 950–957.
   PubMed Web of Science ®Google Scholar
• Sabaté, E.. (2003). Adherence to long-term therapies: Evidence for action (Vol. ISBN 92-4-154599-2). Geneva, Switzerland: World Health Organisation.
   Google Scholar
• Selby, P. (2006). Psychopharmacology of smoking cessation in patients with mental illness. Journal of Psychiatry and Neuroscience, 31(5), 360.
   PubMed Web of Science ®Google Scholar
• Slade, M. (2009). 100 ways to support recovery Retrieved from https://www.rethink.org/media/704895/100_ways_to_support_recovery_2nd_ edition.pdf
   Google Scholar
• Stathopoulou, G., Powers, M. B., Berry, A. C., Smits, J. A. J., & Otto, M. W. (2006). Exercise interventions for mental health: A quantitative and qualitative review. Clinical Psychology: Science and Practice, 13(2), 179–193. doi:10.1111/j.1468-2850.2006.00021.x
   Web of Science ®Google Scholar
• Taj, F., Tanwir, M., Aly, Z., Khowajah, A., Tariq, A., Syed, F…., Shahzada, K. (2008). Factors associated with non-adherence among psychiatric patients at a tertiary care hospital, Karachi, Pakistan: A questionnaire based cross-sectional study. Journal of the Pakistan Medical Association 58(8), 432–436.
   PubMedGoogle Scholar
• Tesfay, K., Girma, E., Negash, A., Tesfaye, M., & Dehning, S. (2013). Medication non-adherence among adult psychiatric out patient in Jimma University specilized hospital, southwest Ethiopia. Ethiopian Journal of Health Science, 23(3), 227–236.
   PubMedGoogle Scholar
• Treatment Advocacy Center. (2014). Why Do Some Individuals with Serious Mental Illness Refuse to Take Medication? Retrieved January 16, 2016, from http://www.treatmentadvocacycenter.org/storage/documents/why%20do% 20some%20individuals%20with%20serious%20mental%20illness%20refu- se%20to%20take%20medication%20final.pdf
   Google Scholar
• van Servellen, G., Heise, B., & Ellis, R. (2011). Factors associated with antidepressant medication adherence and adherence-enhancement programmes: A systematic literature review. Mental Health in Family Medicine, 8, 255–271.
   PubMedGoogle Scholar
• Walsh, R. (2011). Lifestyle and mental health. American Psychologist, 66(7), 579.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Kong, M. C., & Ko, Y. (2012). Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thrombosis and Haemostasis, 108(4), 789–795.
   PubMed Web of Science ®Google Scholar
• Wilder, C., Elbogen, E., Moser, L., Swanson, J., & Swartz, M. (2010). Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. Psychiatric Services, 61(4), 280–285.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). (2011). Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. Geneva, Switzerland: World Health Organisation.
   Google Scholar
• World Health Organisation (WHO). ttp://www.who.int/substance_abuse/research _tools/translation/en/index.html.). Process of Translation and Adaptation. Retrieved March, 2013, from http://www.who.int/substance_abuse/research_tools/translation/en/index.html
   Google Scholar
• World Health Organisation (WHO). (2016). Schizophrenia, from http://www.who.int/mental_health/management/schizophrenia/en/
   Google Scholar
• World Medical Association Declaration of Helsinki, (WMA). (2008). Ethical principles for medical research involving human subjects. Seoul. 1–5
   Google Scholar
• Wynaden, D., Barr, L., Omari, O., & Fulton, A. (2012). Evaluation of service users’ experiences of participating in an exercise programme at the Western Australian State Forensic Mental Health Services. International Journal of Mental Health Nursing, 21(3), 229–235.
   PubMed Web of Science ®Google Scholar
• Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159(10), 1653–1664.
   PubMed Web of Science ®Google Scholar